MediView logo
  • Home
  • Technology
        • About Our TechDiscover our technology and how it works.
        • OmnifyXR®Customize workflow visualization, unlock greater potential of imaging, and facilitate enhanced ergonomics for procedures.
        • MediView XR90Experience unprecedented 3D views of patient internal anatomy to plan and execute procedures with increased confidence.
  • About
        • About UsWe’re on a mission to advance healthcare delivery with intuitive visualization.
        • TeamMeet the great minds who are transforming diagnostic imaging, surgical navigation, and patient care.
        • Visionary EducationDiscover AR solutions to enhance learning and improve student outcomes.
        • CareersJoin us as we drive our vision forwards and learn more about open opportunities at MediView.
  • In The News
  • Publications
  • Contact
Contact
Mediview Announces New Clinical Advisory Board Member (Jordan Tasse)

Mediview Announces New Clinical Advisory Board Member (Jordan Tasse)

MediView XR, Inc. is pleased to announce the addition of Dr. Jordan Tasse as a new member to the MediView Clinical Advisory Board. Dr. Tasse is the Director of Interventional Oncology at Rush University Medical Center and a Vascular and Interventional Radiologist.

“We are thrilled to welcome Dr. Jordan Tasse to our Board of Directors. His extensive expertise in interventional oncology and his commitment to advancing innovative medical treatments align perfectly with MediView’s vision. Dr. Tasse’s distinguished career and leadership in the medical community will bring invaluable insights to our clinical advisory board, driving forward our mission to deliver cutting-edge healthcare solutions. We are confident that his contributions will significantly impact our strategic direction and growth,” said Mina Fahim, MediView CEO and President.

Dr. Tasse has held a long-standing academic appointment at Rush University Medical Center, where he serves as an Associate Professor in the Department of Radiology, Division of Interventional Radiology. Since 2017, he has been the Director of Interventional Oncology at Rush University Medical Center, leading advancements in minimally invasive cancer treatments. His leadership roles have also included positions as Interim Program Director for both the integrated and independent interventional radiology residency programs and Associate Program Director for the vascular and interventional radiology fellowship and residency programs.

Dr. Tasse is highly credentialed, holding active certifications and licensures, including a subspecialty CAQ certification in Vascular and Interventional Radiology from the American Board of Radiology. His membership in professional societies, such as the Society of Interventional Oncology and the Society of Interventional Radiology, highlights his commitment to advancing his field. He is also an active participant in teaching and mentorship, having trained numerous fellows, residents, and medical students throughout his career, making significant contributions to the academic and clinical development of future medical professionals. Dr. Tasse completed his Bachelor of Science in Microbiology and Chemistry from Ohio University, received his Master’s in Physiology from Rosalind Franklin University of Medicine and Science, and earned his Doctor of Medicine from the Chicago Medical School and Rosalind Franklin U-Med and Science.

Related posts:

adam rakestraw on x ray vision newsMovers & Shakers: Adam Rakestraw on X-ray vision, building his own house and pivoting from law to medical tech MediView XR Gives Surgeons an Inside Look. MediView TechnologyMediView enters into know-how agreement with Mayo Clinic to advance clinical extended reality solutions Mediview Announces New Clinical Advisory Board Member (Francois)

Related posts:

Entrepreneurs ‘Xcelerate’ Innovation At Pitch Competition

HoloLens To Assess The Resectability Of Ovarian Cancer

MediView XR Receives Investment from JobsOhio Growth Capital Fund

Medivew, Transformational Augmented Reality Medtech Company, Secures $9.9 Million Safe Funding

MediView XR, Inc. Secures $15M Strategic Funding Round with Backing from Leading Collaborators across Clinical, Industry and Government

Browse Topics

  • News
216-306-1977
info@mediview.com

Technology

  • About Our Tech
  • OmnifyXR
  • Mediview XR90

About

  • Careers
  • Visionary Education
  • Team
  • About Us

Insights

  • In The News
  • Publications

© 2025 MediView XR, Inc. All Rights Reserved.

Privacy Policy | Terms of Service